0.08 -0.01 (-11.11%)

New 52W Low today

4.0M XNAS Volume

High vol.+loss this week

XNAS 31 Mar, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Onconetix Inc is on 11 Apr 2025 for the purpose of Onconetix Inc Annual Report for 2024 See details


Insider Trading disclosures for Onconetix Inc

The latest disclosure was made by Andrew J. Oakley in Onconetix Inc where a trade of 1,709 Common Stock done was reported to US exchanges on March 23, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Andrew J. Oakley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2025 1,709 1,709 - 0 Common Stock
Christian Bruhlmann Chief Strategy Officer 20 Dec 2024 177,462 611,372 - 0 Common Stock
Ralph Schiess Interim CEO, CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2024 177,462 673,365 - 0 Common Stock
Ajit Singh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Sep 2024 3,318 3,396 - 0 Common Stock
Thomas Meier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Sep 2024 3,318 3,318 - 0 Common Stock
James Sapirstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Sep 2024 3,318 3,477 - 0 Common Stock
Simon Tarsh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Sep 2024 3,318 3,477 - 0 Common Stock
Timothy R. Ramdeen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Sep 2024 3,318 3,477 - 0 Common Stock
Christian Bruhlmann Chief Strategy Officer 24 Sep 2024 428,010 433,910 - - Common Stock
Ralph Schiess Interim CEO & CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Sep 2024 489,160 495,903 - - Common Stock
Singh Ajit Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2024 3,125 3,125 - 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures